Hottest Stocks (Over $10)	Hottest Stocks ($2-$10)	Biggest Losers (Over $10)	Biggest Losers ($2-$10)	Hottest Industries	Hottest Sectors	EPS / Sales Surprises
Enter Ticker Symbol:   Ticker Lookup Company Quote Company Profile Research Summary EPS Consensus Perspective Insider Transactions Price Performance

Enter any portion of the company’s name to find its corresponding ticker symbol:

Search for :

Zacks Company Profile for Alpha Cognition Inc. (ACOG : NSDQ)

• Company Description    Alpha Cognition Inc. is a clinical stage biopharmaceutical company. It involved in developing treatments for under-served neurodegenerative diseases, such as Alzheimer's Dementia and Amyotrophic Lateral Sclerosis. Alpha Cognition Inc. is based in Vancouver, British Columbia. Number of Employees: 57

• Price / Volume Information    Yesterday's Closing Price: $9.80 Daily Weekly Monthly 20 Day Moving Average: 70,700 shares Shares Outstanding: 16.16 (millions) Market Capitalization: $158.38 (millions) Beta: 2.71 52 Week High: $11.54 52 Week Low: $3.75 Short Interest Ratio:   % Price Change % Price Change Relative to S&P 500 4 Week 22.50% 20.35% 12 Week 9.68% -0.37% Year To Date 66.38% 48.25%

• Address & Contact Information Street Address Phone / Fax Email Address Web URL 1452 Hughes Rd. Ste. 200 - Grapevine,TX 76051 CAN ph: 858-344-4375 fax: - ir@alphacognition.com http://www.alphacognition.com

• General Corporate Information    Officers Michael McFadden - Chief Executive Officer Henry Du - Chief Financial Officer; Vice President of Finance Len Mertz - Director Kenneth Cawkell - Director John Havens - Director Peer Information - (-) - (-) - (-) - (-) - (-) - (-) Industry / Sector / Ticker Info Analyst Coverage: No Industry Group: MED-BIOMED/GENE Sector: Medical CUSIP: 02074J501 SIC: 2836 Fiscal Year Fiscal Year End: December Last Reported Quarter: 06/01/25 Next Expected EPS Date: 11/13/25 Share - Related Items Shares Outstanding: 16.16 Most Recent Split Date: 11.00 (0.04:1) Beta: 2.71 Market Capitalization: $158.38 (millions)

• EPS Information     • Dividend Information Analyst Coverage: No Dividend Yield: 0.00% Current Fiscal Quarter EPS Consensus Estimate: $-0.46 Indicated Annual Dividend: $0.00 Current Fiscal Year EPS Consensus Estimate: $-1.51 Payout Ratio: Number of Estimates in the Fiscal Year Consensus: 2.00 Change In Payout Ratio: Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00 Next EPS Report Date: 11/13/25

• Fundamental Ratios P/E Current FY Estimate: - Trailing 12 Months: - PEG Ratio: - Price Ratios Price/Book: 3.85 Price/Cash Flow: - Price / Sales: - EPS Growth vs. Year Ago Period: -160.00% vs. Previous Quarter: -225.00% Sales Growth vs. Year Ago Period: -% vs. Previous Quarter: -43.39% ROE 06/30/25 - -80.16 03/31/25 - -65.83 12/31/24 - -157.25 ROA 06/30/25 - -60.95 03/31/25 - -48.21 12/31/24 - -95.72 Current Ratio 06/30/25 - - 03/31/25 - 17.14 12/31/24 - 15.00 Quick Ratio 06/30/25 - - 03/31/25 - 16.83 12/31/24 - 14.81 Operating Margin 06/30/25 - - 03/31/25 - - 12/31/24 - - Net Margin 06/30/25 - - 03/31/25 - - 12/31/24 - - Pre-Tax Margin 06/30/25 - - 03/31/25 - -397.44 12/31/24 - - Book Value 06/30/25 - - 03/31/25 - 2.55 12/31/24 - 2.59 Inventory Turnover 06/30/25 - - 03/31/25 - 2.23 12/31/24 - 0.00 Debt-to-Equity 06/30/25 - - 03/31/25 - 0.00 12/31/24 - 0.00 Debt-to-Capital 06/30/25 - - 03/31/25 - 0.00 12/31/24 - 0.00

Powered by Zacks Investment Research ©